Under construction – not a live service
Sign in
Taking people in DenmarkNo phase

Breathing Device Therapy Before and After Hip Fracture Surgery

Tests a breathing device, PEP therapy, to prevent pneumonia in adults with hip fracture.

Plain-language title generated from the registry record
Registry title: Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia

Key facts

Where
Copenhagen and Herlev, DenmarkSee the 2 sites

Where in Denmark

  • Bispebjerg-Frederiksberg HospitalCopenhagen, DenmarkTaking people
  • Herlev & Gentofte HospitalHerlev, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital Bispebjerg and Frederiksberg
Trial code
NCT07189260
Record updated
23 September 2025
Original description
The goal of this clinical trial is to investigate whether pre- and postoperative treatment with systematic PEP therapy can prevent hospital-acquired pneumonia in patients with hip frac-ture. It will also learn about the barriers regarding PEP therapy in this group of patients.Read full original descriptionShow less

Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia in Patients Undergoing Hip Fracture Surgery

The goal of this clinical trial is to investigate whether pre- and postoperative treatment with systematic PEP therapy can prevent hospital-acquired pneumonia in patients with hip frac-ture. It will also learn about the barriers regarding PEP therapy in this group of patients.

* Does pre- and postoperative treatment with systematic PEP therapy prevent hospital-acquired pneumonia in patients with hip fracture? * Which barriers do participants have regarding PEP therapy in this group of patients? Researchers will compare systematic PEP therapy to no intervention besides standard treat-ment to see if systematic therapy with PEP can prevent hospital-acquired pneumonia.

Participants will:

* Receive systematic PEP therapy during hospitalization or no intervention besides standard treatment * Register the PEP therapy four times daily on a paper checklist. Failure to perform the treatment and the reason must also be documented on the checklist.

Inclusion: Hip fracture regardless of age; Cognitively well-functioning; Able to understand the study and give informed consent; Able to speak and understand Danish; Resident of Region Hovedstaden or Region Sjælland.

Exclusion: Pneumothorax; For patients with e.g. dementia or brain injury, the ability to give informed consent will be assessed individually; Cognitively impaired; Unable to understand the study and give informed consent; Pneumonia upon admission; Delirium upon admission.

ClinicalTrials.gov NCT07189260